跳至主要内容
临床试验/NCT03023982
NCT03023982Unknown2 期

Ultrasound Guided PECs II (Pectoralis and Serratus Nerves) Block in Patients Undergoing a Thoracic Surgery

Soroka University Medical Center0 个研究点目标入组 168 人开始时间: 2017年2月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
入组人数
168
主要终点
Comparison Visual Analog Score between groups

研究概览

简要总结

A new conceptual regional anesthesia the PECs II block (modified pectoral and serratus nerves block) has been described for pain control after thoracic surgery, one of the indications to perform this method is analgesia for surgeries or procedures involving lateral chest wall

详细描述

The PECs I block was found to be very effective after breast cancer surgery and sub-pectoral prosthesis for pain control management.

This block is provided by injection into another myofascial plane, this time between pectoralis minor and serratus anterior muscle at the level of 3rd and 4th rib.PECs II block is simple in performance with a high success rate and minimal incidence of complications, especially, if used ultrasound approach that gives a good understanding of anatomy of the lateral thoracic wall.

In present clinical trial we are going to compare PECs block for pain control with traditional pain management techniques based on IV opioids and NSAIDs treatment in patient undergoing thoracic surgery in early postoperative period.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Double (Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All patients undergoing thoracic surgery, older ≥18 years
  • Patients who meet criteria of ASA I-II-III class.

排除标准

  • Patients who will be unconscious or mentally incompetent
  • Patients refusal to participate in the study
  • Patient with coagulopathy
  • Hemodynamically unstable (systolic BP < 90, HR > 100)
  • Allergy to local anesthetic drugs or opioids
  • Pregnant patient
  • History of opioid abuse

研究组 & 干预措施

Pectoralic block group

Experimental

After general anesthesia, 40ml of 0.25% Bupivacaine Hydrochloride will be administered before procedure Thoracotomy. Block will be administrated between pectoralis minor and serratus anterior muscle at the 3rd and 4th rib., in assistance of ultrasound for visualization anesthetic injection point.

干预措施: Bupivacaine Hydrochloride (Drug)

Pectoralic block group

Experimental

After general anesthesia, 40ml of 0.25% Bupivacaine Hydrochloride will be administered before procedure Thoracotomy. Block will be administrated between pectoralis minor and serratus anterior muscle at the 3rd and 4th rib., in assistance of ultrasound for visualization anesthetic injection point.

干预措施: Ultrasound (Device)

Pectoralic block group

Experimental

After general anesthesia, 40ml of 0.25% Bupivacaine Hydrochloride will be administered before procedure Thoracotomy. Block will be administrated between pectoralis minor and serratus anterior muscle at the 3rd and 4th rib., in assistance of ultrasound for visualization anesthetic injection point.

干预措施: Thoracotomy (Procedure)

Pectoralic block group

Experimental

After general anesthesia, 40ml of 0.25% Bupivacaine Hydrochloride will be administered before procedure Thoracotomy. Block will be administrated between pectoralis minor and serratus anterior muscle at the 3rd and 4th rib., in assistance of ultrasound for visualization anesthetic injection point.

干预措施: Opioids (Drug)

Pectoralic block group

Experimental

After general anesthesia, 40ml of 0.25% Bupivacaine Hydrochloride will be administered before procedure Thoracotomy. Block will be administrated between pectoralis minor and serratus anterior muscle at the 3rd and 4th rib., in assistance of ultrasound for visualization anesthetic injection point.

干预措施: NSAID (Drug)

Control group

Active Comparator

Patients in this group will receive standard pain control with opioids and NSAIDs

干预措施: Thoracotomy (Procedure)

Control group

Active Comparator

Patients in this group will receive standard pain control with opioids and NSAIDs

干预措施: Opioids (Drug)

Control group

Active Comparator

Patients in this group will receive standard pain control with opioids and NSAIDs

干预措施: NSAID (Drug)

结局指标

主要结局

Comparison Visual Analog Score between groups

时间窗: First 24 hours from the surgery

First VAS after admission in PACU

次要结局

  • Total NSAIDs dosage (mg) in the PACU and department(First 24 hours from the surgery)
  • Length of hospital stay(up to 21 days)
  • Total morphine dosage (mg) in the PACU and department(First 24 hours from the surgery)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Semionov Michael

Primary Investigator

Soroka University Medical Center

相似试验